Antiviral therapy of HSV-1 and -2 infections

Antiviral therapy of HSV-1 and -2 infections

DOI：10.3969/j.issn.1672-6731.2011.05.006

Bibliographic Details
Main Authors:	Fang GUO, Dexin WANG
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2011-10-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/58

Similar Items

Superior antiviral activity of IFNβ in genital HSV-1 infection
by: Yasmin Schmitz, et al.
Published: (2022-10-01)

Lactoferrin-Functionalized Noble Metal Nanoparticles as New Antivirals for HSV-2 Infection
by: Malgorzata Krzyzowska, et al.
Published: (2022-01-01)

HSV-1 Infection of Epithelial Dendritic Cells Is a Critical Strategy for Interfering with Antiviral Immunity
by: Yang Gao, et al.
Published: (2022-05-01)

Antiviral Effect Assay of Thymus Kotschyanus on HSV-1 Multiplication
by: Malihe Farahani
Published: (2017-11-01)

Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections.
by: Melissa Swiecki, et al.
Published: (2013-10-01)

Mechanistic Understanding of the Antiviral Properties of Pistachios and Zeaxanthin against HSV-1
by: Rosamaria Pennisi, et al.
Published: (2023-07-01)

Novel Cationic Meso-Arylporphyrins and Their Antiviral Activity against HSV-1
by: Kseniya A. Zhdanova, et al.
Published: (2021-03-01)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
by: Bélec Laurent, et al.
Published: (2007-01-01)

The study of Antiviral Effects of Glycyrrihza Glabra Extract on HSV
by: SHR Monavari, et al.
Published: (2008-11-01)

TRIM26 Facilitates HSV-2 Infection by Downregulating Antiviral Responses through the IRF3 Pathway
by: Tushar Dhawan, et al.
Published: (2021-01-01)

Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons
by: Baeten Jared M, et al.
Published: (2011-03-01)

Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
by: Gill Diamond, et al.
Published: (2021-03-01)

Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.
by: Catherine M Byrne, et al.
Published: (2018-04-01)

Antiviral Effect Assay of Thymus Kotschyanus and Nerium Oleander on HSV-1 in Vitro
by: M Farahani
Published: (2013-06-01)

Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infection
by: Carolyn Samer, et al.
Published: (2024-02-01)

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
by: Daan W. Huntjens, et al.
Published: (2023-01-01)

Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1
by: Ilina Bhattacharya, et al.
Published: (2022-04-01)

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity
by: Ding X, et al.
Published: (2012-05-01)

Elsberg syndrome in HSV-2 infection
by: Omar Belfaqeeh, et al.
Published: (2023-01-01)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
by: Peter B Gilbert, et al.
Published: (2017-01-01)

Analysis of the SUMO2 Proteome during HSV-1 Infection.
by: Elizabeth Sloan, et al.
Published: (2015-07-01)

A Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes
by: Miles C. Smith, et al.
Published: (2014-12-01)

Sensing of HSV-1 by the cGAS–STING pathway in microglia orchestrates antiviral defence in the CNS
by: Line S. Reinert, et al.
Published: (2016-11-01)

Function and Mechanism of Antiviral Wasp Venom Peptide Protopolybia-MP III and Its Derivatives against HSV-1
by: Fang Sun, et al.
Published: (2024-03-01)

Antiviral Activity of <i>Vitis vinifera</i> Leaf Extract against SARS-CoV-2 and HSV-1
by: Carla Zannella, et al.
Published: (2021-06-01)

Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response
by: Kevin A. Cassady, et al.
Published: (2009-10-01)

Antiviral mechanism of carvacrol on HSV-2 infectivity through inhibition of RIP3-mediated programmed cell necrosis pathway and ubiquitin-proteasome system in BSC-1 cells
by: Li Wang, et al.
Published: (2020-11-01)

Dynamics of HSV-2 infection with a therapeutic vaccine
by: Ezio Venturino, et al.
Published: (2020-07-01)

Single therapeutic dose of an antiviral UL29 siRNA swarm diminishes symptoms and viral load of mice infected intranasally with HSV‐1
by: Tuomas Lasanen, et al.
Published: (2023-05-01)

Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease
by: Yike Jiang, et al.
Published: (2017-09-01)

Stepwise release of biologically active HMGB1 during HSV-2 infection.
by: Chloé Borde, et al.
Published: (2011-01-01)

The modulation of phosphatase expression impacts the proliferation efficiency of HSV-1 in infected astrocytes.
by: Lei Yue, et al.
Published: (2013-01-01)

A theoretical model for the transmission dynamics of HIV/HSV-2 co-infection in the presence of poor HSV-2 treatment adherence
by: Mhlanga A.
Published: (2018-12-01)

A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.
by: Federica Crostarosa, et al.
Published: (2009-11-01)

HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part I. HSV-1 Structure, Replication and Pathogenesis
by: Andreas Jacobs, et al.
Published: (1999-11-01)

Potential for HSV-1 vaccination to reduce risk of HSV-1 encephalitis and/or Alzheimer's disease?
by: Esiri, M
Published: (2001)

Screening and verification of antiviral compounds against HSV-1 using a method based on a plaque inhibition assay
by: Yingxian Yin, et al.
Published: (2023-12-01)

Stress Hormones Epinephrine and Corticosterone Selectively Reactivate HSV-1 and HSV-2 in Sympathetic and Sensory Neurons
by: Poorna Goswami, et al.
Published: (2022-05-01)

Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
by: David M J Houston, et al.
Published: (2017-01-01)

Cellular Processes Induced by HSV-1 Infections in Vestibular Neuritis
by: Zhengdong Zhao, et al.
Published: (2023-12-01)